| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/26/2001 | WO2001052813A1 Multi-spike release formulation for drug delivery |
| 07/26/2001 | WO2001052812A1 Diclofenamide suspension gel |
| 07/26/2001 | WO2001052741A1 Luminescent in vivo glucose measurement |
| 07/26/2001 | WO2001052651A2 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 07/26/2001 | WO2001052634A2 Delivering substances to invertebrate organisms |
| 07/26/2001 | WO2001022944A8 Oral controlled release formulations |
| 07/26/2001 | WO2001015726A3 Compositions for stimulating cytokine secretion and inducing an immune response |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001013891A3 Modulation of release from dry powder formulations |
| 07/26/2001 | WO2001008663A3 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 07/26/2001 | WO2001007058A3 Parenteral cisplatin emulsion |
| 07/26/2001 | WO2001005372A3 A liposome composition having resistance to freeze/thaw damage |
| 07/26/2001 | WO2001003666A3 Liquid based vaso-occlusive compositions |
| 07/26/2001 | WO2001003625A3 Exothermic bandage |
| 07/26/2001 | WO2001001966A3 Sustained release dosage form unit having latex coating and method of making the same |
| 07/26/2001 | WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/26/2001 | WO2000069915A3 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES |
| 07/26/2001 | WO2000049990A3 The process for manufacturing topical ophthalmic preparations without systemic effects |
| 07/26/2001 | WO2000044356A9 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 07/26/2001 | US20010009995 Oxybutynin therapy |
| 07/26/2001 | US20010009961 The reaction product of an alkali cellulose with a hydroxypropylating agent is granulated and the resulting granular material is neutralized with acid |
| 07/26/2001 | US20010009687 Mixing of the dextrose sweetening component with gelatin binder, kneading, rolling, stamping to produce lozenges, and drying of lozenges obtained, wherein the binder is introduced in several portions into the sweetening component |
| 07/26/2001 | US20010009679 Fat soluble vitamin dispersed in a matrix of an emulsion-forming natural polysaccharide gum and/or a protein; beverages, tablets, cosmetics; powder in form of nanoparticles |
| 07/26/2001 | US20010009678 Drug such as lansoprazole, voglibose, or candesartan cilexetil, water soluble sugar alcohol, and low-substituted hydroxypropyl cellulose; tablet with improved buccal disintegration or dissolution |
| 07/26/2001 | US20010009677 Sterol esters in tableted solid dosage forms |
| 07/26/2001 | US20010009673 For controlled release of gestagens such as levonorgestrel, and optionally estrogen in a matrix of an N-vinyllactam copolymer with acrylic acids, esters and amides, and/or vinyl esters; steroids do not crystallize out, storage stability |
| 07/26/2001 | US20010009671 For regulating the oily and/or shiny appearance of skin; comprising a panthenol oil regulating agent, a particulate, oil-absorbing polymer such as crosslinked ethylene glycol dimethacrylate-allyl ether copolymer, and a carrier |
| 07/26/2001 | US20010009670 Parenterally administering large liposomes comprised of phospholipids substantially free of sterol, where the liposomes pick-up cholesterol |
| 07/26/2001 | US20010009661 Preparing an iodine demand disinfectant by contacting at high temperature and pressure a porous strong base anion exchange resin in salt form with iodine or polyiodide ion absorbable by the resin to form the polyiodide-resin |
| 07/26/2001 | US20010009151 Two-chamber cartridge for propellant-free metering aerosols |
| 07/26/2001 | DE19960225A1 Raum- oder Kristallform mindestens eines Polypeptids pro asymmetrischer Einheit, enthaltend mindestens eine an der Katalyse beteiligte (Sub)-Domäne eines Calpains Spatial or crystal form of at least one polypeptide per asymmetric unit containing at least one involved in catalysis (sub) domain of calpain |
| 07/26/2001 | DE10100779A1 Formulierung Formulation |
| 07/26/2001 | DE10024312A1 Process to modify adsorption properties fine-pored molecular sieve by contact with dissolved agent under super-critical conditions |
| 07/26/2001 | DE10001729A1 Treatment or prevention of hepatitis C infection by administration of certain bicyclic compounds, e.g. 2-methyl-1,4-naphthoquinone |
| 07/26/2001 | DE10001172A1 Templatieren von Feststoffpartikeln mit Polymermultischichten Templating of solid particles with polymer multilayers |
| 07/26/2001 | DE10001096A1 Transdermal therapeutic system for prolonged release of drugs, e.g. steroid hormones, including reservoir providing slow release of perfume to improve patient compliance |
| 07/26/2001 | DE10000577A1 Treating mitochondrial diseases, e.g. Parkinson's or Alzheimer's disease or retinitis pigmentosa, using fumaric acid derivative, e.g. mono- or dialkyl fumarate, having succinate dehydrogenase stimulating activity |
| 07/26/2001 | CA2398970A1 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 07/26/2001 | CA2398086A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | CA2397871A1 Novel podophyllotoxin compositions |
| 07/26/2001 | CA2397792A1 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | CA2397490A1 Effervescent tablet, effervescent tablet for bath agent, effervescent tablet for washing detergent, effervescent tablet for oral administration and production methods thereof |
| 07/26/2001 | CA2397202A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | CA2397065A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | CA2396938A1 Delivering substances to invertebrate organisms |
| 07/26/2001 | CA2396870A1 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 07/26/2001 | CA2396381A1 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | CA2396319A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | CA2395974A1 Multi-step drug dosage forms |
| 07/26/2001 | CA2394612A1 Antimicrobial compositions |
| 07/26/2001 | CA2393694A1 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 07/25/2001 | EP1118326A2 Reduction of liposome-induced adverse physiological reactions |
| 07/25/2001 | EP1118325A2 Drug delivery systems containing microtubule stabilizing agents and the use of said agents in the manufacture of a medicament for treating atherosclerosis or restenosis |
| 07/25/2001 | EP1118321A1 Solid pharmaceutical compositions for the controlled delivery of active substances |
| 07/25/2001 | EP1118270A1 Dextrose based lozenges and method of production |
| 07/25/2001 | EP1117807A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117768A1 Dnazymes and methods for treating restenosis |
| 07/25/2001 | EP1117736A1 Modified starch film compositions |
| 07/25/2001 | EP1117726A1 Urethane(meth)acrylates containing siloxane groups and able to undergo free-radical polymerisation |
| 07/25/2001 | EP1117720A1 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 07/25/2001 | EP1117696A1 Method for producing powder-shaped cross-linked polymerizates |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117643A1 New crystal modification iii of torasemide |
| 07/25/2001 | EP1117516A1 A method for producing a layered product |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117442A1 Dry powder active agent pulmonary delivery |
| 07/25/2001 | EP1117441A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/25/2001 | EP1117440A1 Pharmaceutical compositions containing paclitaxel |
| 07/25/2001 | EP1117412A1 Compositions containing diphosphonic acids |
| 07/25/2001 | EP1117411A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 07/25/2001 | EP1117407A1 Oral dosage formulations comprising (2s, 3s,5r)-2-(3,5-difluorophenyl) -3,5-dimethyl-2-morpholinol and an effective stabilizing amount of alginic acid |
| 07/25/2001 | EP1117406A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117400A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP1117388A1 Antioxidant gel for gingival conditions |
| 07/25/2001 | EP1117387A2 Coated medicament forms with controlled active substance release |
| 07/25/2001 | EP1117386A1 Enteric and colonic delivery using hpmc capsules |
| 07/25/2001 | EP1117385A1 Aqueous enteric coating composition with low gastric permeability |
| 07/25/2001 | EP1117384A1 Controlled release nanoparticulate compositions |
| 07/25/2001 | EP1117383A1 Dosage form comprising therapeutic formulation |
| 07/25/2001 | EP1117382A1 Spray coated microparticles for use in needleless syringes |
| 07/25/2001 | EP1117381A1 Calcium phosphate delivery vehicle and adjuvant |
| 07/25/2001 | EP1117380A1 Glucoside paucilamellar vesicles |
| 07/25/2001 | EP1117379A1 Foamable formulation and foam |
| 07/25/2001 | EP1117378A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/25/2001 | EP1117357A1 Methods and apparatus for improved administration of pharmaceutically active compounds |
| 07/25/2001 | EP1117356A1 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 07/25/2001 | EP1117350A1 Flexible transmyocardial implant inducing angiogenesis |
| 07/25/2001 | EP0927025A4 Liposome encapsulated active agent dry powder composition |
| 07/25/2001 | EP0830126B1 Stabilized pseudo-emulsions and their preparation process |
| 07/25/2001 | EP0814773B1 Pectin liquid pharmaceutical compositions |
| 07/25/2001 | EP0814770B1 Process for the preparation of a solid pharmaceutical dosage form |
| 07/25/2001 | EP0782440B1 Injection-molded dosage form |
| 07/25/2001 | EP0767656B1 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
| 07/25/2001 | EP0751760B1 Treatment of ultraviolet radiation-induced erythema |
| 07/25/2001 | EP0739206B1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 07/25/2001 | EP0722338B1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/25/2001 | EP0708657B1 Compositions for nasal administration of desmopressin |